Articles related to COVID-19

The “revolving door” phenomenon, exemplified by the transition of Doran Fink from the FDA to Moderna, raises critical questions about public trust and regulatory integrity. As healthcare professionals, understanding these dynamics can inform our perspectives on regulatory processes and pharmaceutical industry relationships.

The potential of the antiviral combo in reducing the risk of thromboembolic events among post-COVID-19 patients is real. Could it pave the way for more targeted therapeutic strategies in managing post-COVID-19 conditions?

Recent studies have indicated a potential increase in stroke risk among seniors, particularly those aged 85 and older, who receive both COVID-19 and influenza vaccines simultaneously. This finding has sparked a renewed focus on the safety of administering multiple vaccines at the same time.

Healthcare professionals should be aware of the potential for neurological side effects in patients receiving COVID-19 vaccines. With nearly one-third of vaccine recipients experiencing symptoms such as headaches, tremors, and insomnia, continued monitoring and research are crucial.

A recent case study underscores an unexpected consequence of prolonged mask-wearing. A 91-year-old woman developed tinea faciei, a filamentous fungal infection, likely due to wearing a mask every day for almost the entire day.

In an intriguing development, a recent study has demonstrated that green tea, matcha, and black tea can effectively inactivate COVID-19 Omicron subvariants. This discovery could potentially influence our approach towards mitigating the impact of the pandemic.